- » Key resources and services
- » Programs and projects
- » ETHOS cohort (Enhancement treatment for hepatitis C in opioid substitution settings)
ETHOS cohort (Enhancement treatment for hepatitis C in opioid substitution settings)
The purpose of the study is to examine hepatitis C virus (HCV) treatment uptake, response to therapy and reinfection following successful treatment among patients with chronic HCV infection and a history of injection drug use.
The specific objectives of this study are to examine:
- assessment and treatment of HCV in a prospective cohort study, including uptake and response of HCV treatment and associated factors
- patient and provider attitudes and barriers towards the provision of services for assessment and treatment of HCV infection
- peer based support as a strategy for enhancing knowledge and uptake of treatment for HCV infection
- cost effectiveness of providing assessment and treatment for HCV infection in the opiate substitution setting.
Abstract adapted from The Kirby Institute for Infection and Immunity in Society
The Kirby Institute for Infection and Immunity in Society
101 West Streets
Darlinghurst NSW 2010
Ph: (02) 9385 0900
Fax: (02) 9385 0920